Skip to main content

Table 2 Pulmonary Function Testing (PFTs)

From: Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series

 

PFTs at diagnosis (N = 40)

Last PFTs (N = 25)

Total mean change from first to last PFT, % predicted (N = 25)

Mean % change per year

P-value

Obstruction, N (%)

34 (85.0)

21 (84.0)

   

TLC% (median (IQR))

106 (88.0–115.0)

112 (105.0–123.0)

4.8

1.5 (N = 15)

0.46

RV/TLC% (median (IQR))

158 (144.0–181.5)

152 (146.3–166.8)

− 6.6

− 1.7 (N = 14)

0.07

FVC% (median (IQR))

66 (53.0–75.0)

61 (54.5–74.5)

− 1.9

− 0.5 (N = 25)

0.42

FEV1% (median (IQR))

40 (31.0–52.5)

41 (29.5–48.0)

−1.5

−0.4 (N = 25)

0.43

DLCO% (median (IQR))

69 (57.5–78.0)

64 (57.0–76.8)

−2.3

−0.6 (N = 18)

0.34

Duration between first and last available PFT, months (median (IQR) and mean (SD))

33(14.6–51.7), 42 (40)

    
  1. Abbreviations: TLC% percent of predicted total lung capacity, RV/TLC% percent of predicted residual volume over total lung capacity, FVC% percent of predicted forced vital capacity, FEV1% percent of predicted forced expiratory volume in the first second
  2. ¶Wilcoxon signed rank test for comparing two related samples